Verition Fund Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-15,953
| Closed | -$268K | – | 2873 |
|
2024
Q4 | $268K | Buy |
+15,953
| New | +$268K | ﹤0.01% | 2183 |
|
2024
Q1 | – | Sell |
-1,147
| Closed | -$16.6K | – | 2311 |
|
2023
Q4 | $16.6K | Buy |
+1,147
| New | +$16.6K | ﹤0.01% | 1771 |
|
2023
Q3 | – | Sell |
-8,924
| Closed | -$115K | – | 2223 |
|
2023
Q2 | $115K | Sell |
8,924
-3,446
| -28% | -$44.5K | ﹤0.01% | 1679 |
|
2023
Q1 | $163K | Buy |
+12,370
| New | +$163K | ﹤0.01% | 1655 |
|
2022
Q4 | – | Sell |
-1,019
| Closed | -$12K | – | 2077 |
|
2022
Q3 | $12K | Buy |
+1,019
| New | +$12K | ﹤0.01% | 2238 |
|